Lakhmir Chawla
Directeur/Bestuurslid bij REVELATION BIOSCIENCES, INC.
Profiel
Lakhmir S.
Chawla is currently a Director at ExThera Medical Corp.
and an Independent Director at Revelation Biosciences, Inc. He previously served as an Independent Director at CalciMedica Subsidiary, Inc. from 2018 to 2023, Chief Medical Officer at La Jolla Pharmaceutical Co. from 2015 to 2020, Professor at George Washington University from 2002 to 2014, and Chief-Intensive Care Medicine Division at VA Medical Center (District of Columbia) from 2014 to 2015.
He also held the position of Chief Medical Officer at Silver Creek Pharmaceuticals, Inc. Dr. Chawla completed his undergraduate studies at Boston University and obtained his doctorate from New Jersey Medical School in 1995.
Actieve functies van Lakhmir Chawla
| Bedrijven | Functie | Begin |
|---|---|---|
| REVELATION BIOSCIENCES, INC. | Directeur/Bestuurslid | 27-09-2023 |
ExThera Medical Corp.
 ExThera Medical Corp. Medical/Nursing ServicesHealth Services ExThera Medical Corp. develops medical devices that address unmet clinical needs in the treatment of bloodstream infections and pathogen-reduction in blood banking. The company develops Seraph Microbind Affinity Blood Filter (Seraph), which captures and removes normal and drug-resistant bacteria, viruses, toxins, and pro-inflammatory cytokines from human blood; and offers solution for use in a dialysis, such as extracorporeal circuit for treating existing bloodstream infections. The company was founded in 2007 and is headquartered in Martinez, CA. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Lakhmir Chawla
| Bedrijven | Functie | Einde |
|---|---|---|
Silver Creek Pharmaceuticals, Inc.
 Silver Creek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Silver Creek Pharmaceuticals, Inc. develops novel regenerative medicines. The firm focuses on treating cardiovascular disease. Its molecules are designed to promote resilience and regeneration of damaged tissues after acute or chronic injury. The company was founded in 2010 and is headquartered in San Francisco, CA. | Hoofd Techniek/Wetenschap/O&O | 01-09-2023 |
CalciMedica, Inc. (US)
 CalciMedica, Inc. (US) BiotechnologyHealth Technology CalciMedica, Inc. is a holding company, which engages in drug development. It discovers and develops novel small molecule drugs for the treatment of inflammatory and autoimmune disorders and organ transplant rejection. The company was founded by Gonul Velicelebi, Kenneth Stauderman, Anjana Rao, Patrick Hogan, Stefan Feske, Michael Harpold, Tom Reed, and Jack Roos in December 2006 and is headquartered in La Jolla, CA. | Directeur/Bestuurslid | 01-03-2023 |
| LA JOLLA PHARMACEUTICAL COMPANY | Hoofd Techniek/Wetenschap/O&O | 02-10-2020 |
| George Washington University | Corporate Officer/Principal | 01-07-2018 |
| VA Medical Center (District of Columbia) | Corporate Officer/Principal | 01-01-2015 |
Opleiding van Lakhmir Chawla
| New Jersey Medical School | Doctorate Degree |
| Boston University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| REVELATION BIOSCIENCES, INC. | Health Technology |
| Bedrijven in privébezit | 5 |
|---|---|
La Jolla Pharmaceutical Co.
 La Jolla Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology La Jolla Pharmaceutical Co. operates as a biopharmaceutical company. It engages in the discovery, development and commercialization of therapies intended to improve outcomes in patients suffering from life-threatening diseases. Its products portfolio include GIAPREZA and XERAVA. The company was founded in 1989 and is headquartered in San Diego, CA. | Health Technology |
| VA Medical Center (District of Columbia) | Government |
CalciMedica, Inc. (US)
CalciMedica, Inc. (US) BiotechnologyHealth Technology CalciMedica, Inc. is a holding company, which engages in drug development. It discovers and develops novel small molecule drugs for the treatment of inflammatory and autoimmune disorders and organ transplant rejection. The company was founded by Gonul Velicelebi, Kenneth Stauderman, Anjana Rao, Patrick Hogan, Stefan Feske, Michael Harpold, Tom Reed, and Jack Roos in December 2006 and is headquartered in La Jolla, CA. | Health Technology |
ExThera Medical Corp.
ExThera Medical Corp. Medical/Nursing ServicesHealth Services ExThera Medical Corp. develops medical devices that address unmet clinical needs in the treatment of bloodstream infections and pathogen-reduction in blood banking. The company develops Seraph Microbind Affinity Blood Filter (Seraph), which captures and removes normal and drug-resistant bacteria, viruses, toxins, and pro-inflammatory cytokines from human blood; and offers solution for use in a dialysis, such as extracorporeal circuit for treating existing bloodstream infections. The company was founded in 2007 and is headquartered in Martinez, CA. | Health Services |
Silver Creek Pharmaceuticals, Inc.
Silver Creek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Silver Creek Pharmaceuticals, Inc. develops novel regenerative medicines. The firm focuses on treating cardiovascular disease. Its molecules are designed to promote resilience and regeneration of damaged tissues after acute or chronic injury. The company was founded in 2010 and is headquartered in San Francisco, CA. | Health Technology |
